Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

123 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-22

Study Completion Date

2023-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

STOP-FALLS-D is an educational intervention to inform and activate patients, their care partner(s), and their primary care providers to work together to reduce use of central nervous system (CNS) active medications and prevent adverse outcomes (falls and injuries) associated with their use.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Preliminary Clinical Trial- FallScape-D

NCT06656897

Falls

ACTIVE_NOT_RECRUITING EARLY_PHASE1

FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia

NCT03961386

Falls (Accidents) in Old Age

UNKNOWN NA

De-prescribing Program to Evaluate Falls in Older Adults

NCT04272671

COMPLETED NA

Evaluating an In-home Multicomponent Program to Manage Concerns About Falling in Frail Community Dwelling Older People

NCT01358032

Concerns About Falling Aged

COMPLETED NA

Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?

NCT05359679

Dementia Med: Dementia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design is a pragmatic, one-arm pilot trial to test the feasibility and acceptability of implementing a deprescribing intervention with older people with dementia and their care partners in primary care. The intervention consists of patient-facing educational brochures on CNS-active medications and decision support for the primary care provider. Ethnic/minority groups will be over-sampled to ensure a diverse study sample.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Educational Intervention

Group Type EXPERIMENTAL

STOP Falls D Educational Intervention

Intervention Type BEHAVIORAL

This is one-arm, health-system embedded pragmatic pilot trial

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STOP Falls D Educational Intervention

This is one-arm, health-system embedded pragmatic pilot trial

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed dementia (dementia diagnosis code or prescription for dementia medication)
* Receiving primary care at a Kaiser Permanente Washington integrated group practice outpatient clinic
* Prescribed at least one CNS-active medication on a chronic (3 months or more) basis

* Aged 18 years or older
* Self-identify as a care partner for the older adult with dementia